News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Angiotech Pharmaceuticals, Inc. (ANPI) Announces Financial Results for the Fourth Quarter Ended December 31, 2012


3/29/2013 6:40:30 AM

VANCOUVER, March 28, 2013 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. ("Angiotech") announced that it released its financial results for the fourth quarter ended December 31, 2012.

Selected recent developments and highlights include:

* Sale of Interventional Products Business to Argon Medical Devices, Inc. On March 25, 2013, we announced that we entered into a definitive agreement to sell certain of our subsidiaries, comprising Angiotech's Interventional Products Business to Argon Medical Devices, Inc., a Delaware corporation ("Argon"), which is a portfolio company of RoundTable, for $362.5 million in cash consideration.

Read at Reuters

comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES